Friday, April 20, 2018 9:17:02 PM
That was a PR ploy. OMHE has never brought a single prescription med from incubation to human/animal trials to FDA approval to commercial/retail prescription sales.
There is ZERO evidence that any of the OMHE researchers have ever successfully developed a single prescription medication from incubation to market. Zero evidence.
Why would they PR the "fast track" buzzword? because no trader wants to hear that the average is closer to 12 years.
The time window of 3 years "fast track" buys OMHE insiders 3 years worth of time to compensate themselves.
So far, almost $1 mil compensated to insiders for the first two quarters of the current FY.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM